Get the Stockscreener App
2.27
5.42%
-0.13
After Hours:
2.31
0.04
+1.76%
Stereotaxis Inc stock is traded at $2.27, with a volume of 450.59K.
It is down -5.42% in the last 24 hours and up +7.08% over the past month.
Stereotaxis, Inc. designs, manufactures, and markets robotic systems and instruments for the treatment of abnormal heart rhythms in the United States and internationally. Its products include Niobe ES robotic magnetic navigation system that enables physicians to complete interventional procedures by providing image guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and Vdrive system, which offers navigation and stability for the diagnostic and therapeutic devices designed to enhance interventional procedures. The company also offers Odyssey solution, a real-time information solution to manage, control, record, and share procedures across networks. In addition, it provides disposables and other accessories, such as QuikCAS automated catheter advancement disposables for the remote advancement of electrophysiology catheters; and CARTO RMT navigation and ablation system, CELSIUS RMT, NAVISTAR RMT, NAVISTAR RMT DS, NAVISTAR RMT THERMOCOOL, and CELSIUS RMT THERMOCOOL irrigated tip diagnostic/ablation steerable tip catheters. Further, the company's disposables and other accessories include V-CAS and V-CAS Deflect catheter advancement systems; and V-loop circular and V-Sono ICE catheter manipulators. The company markets its products through direct sales force, distributors, and sales agents. The company has a strategic collaboration with Osypka AG to design and develop a next-generation magnetic ablation catheter using Stereotaxis' robotic technology. Stereotaxis, Inc. was founded in 1990 and is headquartered in St. Louis, Missouri.
See More
Previous Close:
$2.40
Open:
$2.4
24h Volume:
450.59K
Relative Volume:
1.22
Market Cap:
$195.22M
Revenue:
$25.14M
Net Income/Loss:
$-21.57M
P/E Ratio:
-8.4074
EPS:
-0.27
Net Cash Flow:
$-12.23M
1W Performance:
+1.34%
1M Performance:
+7.08%
6M Performance:
-6.20%
1Y Performance:
+13.50%
1-Day Range:
$2.25
$2.435
1-Week Range:
$2.20
$2.67
52-Week Range:
$1.54
$2.7155
Stereotaxis Inc Stock (STXS) Company Profile
Name
Stereotaxis Inc
Sector
Industry
Phone
314-678-6100
Address
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
2.27 | 216.60M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
481.09 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.25 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.55 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
271.94 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-10-24 | Initiated | ROTH MKM | Buy |
| Jul-12-22 | Initiated | Aegis Capital | Buy |
| Jun-23-22 | Initiated | B. Riley Securities | Buy |
| Jan-05-22 | Initiated | Craig Hallum | Buy |
| Jan-05-22 | Initiated | Loop Capital | Buy |
| May-26-21 | Initiated | Piper Sandler | Overweight |
| Sep-08-20 | Initiated | Northland Capital | Outperform |
| Apr-09-20 | Initiated | Cowen | Outperform |
| Apr-07-20 | Initiated | Lake Street | Buy |
View All
Stereotaxis Inc Stock (STXS) Latest News
Monogram robot marks autonomy milestone; Stereotaxis catheter cleared - MedTech Dive
Will Stereotaxis Inc. (STXS) Report Negative Earnings Next Week? What You Should Know - Yahoo Finance
What institutional investors are buying Stereotaxis Inc. stockSwing Trade Insights Backed By Experts - jammulinksnews.com
What makes Stereotaxis Inc. stock price move sharplyAI Screening for Swing Trade Picks Finds Momentum - metal.it
How does Stereotaxis Inc. generate profit in a changing economySwing Trade Entry Points For Fast Growth - jammulinksnews.com
Stereotaxis' MAGiC Sweep: A Strategic Inflection Point in Robotic Electrophysiology - AInvest
Stereotaxis wins FDA clearance for diagnostic mapping catheter - Yahoo Finance
Stereotaxis' FDA-Cleared MAGiC Sweep Catheter: A Catalyst for Growth in the Robotic Ablation Era - AInvest
Stereotaxis Wins FDA Nod for MAGiC Sweep EP Catheter - Medical Product Outsourcing
Stereotaxis stock soars after FDA clearance for robotic mapping catheter By Investing.com - Investing.com Canada
Stereotaxis receives FDA clearance for robotic mapping catheter By Investing.com - Investing.com Nigeria
Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter - GlobeNewswire
Revolutionary Cardiac Mapping Breakthrough: FDA Approves First Robotic High-Density EP Catheter - Stock Titan
Should I hold or sell Stereotaxis Inc. stock in 2025Unlock steady growth with low-risk stocks - jammulinksnews.com
What are analysts’ price targets for Stereotaxis Inc. in the next 12 monthsSuperior trading gains - jammulinksnews.com
Does Stereotaxis Inc. stock perform well during market downturnsUnlock exclusive trading strategies for gains - jammulinksnews.com
When is Stereotaxis Inc. stock expected to show significant growthUnlock superior stock analysis tools - jammulinksnews.com
What analysts say about Stereotaxis Inc. stockExceptional financial outcomes - Autocar Professional
What drives Stereotaxis Inc. stock priceFree Stock Movement Tracking - Autocar Professional
Why Stereotaxis Inc. stock attracts strong analyst attentionFree Insider Trading Tips - Newser
Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025 - GlobeNewswire
Leading Surgical Robotics Pioneer Stereotaxis Sets Q2 2025 Earnings Date: Key Details for Investors - Stock Titan
Stereotaxis Inc. Stock Analysis and ForecastRapid capital growth - jammulinksnews.com
Is Stereotaxis Inc. a good long term investmentExceptional gains - jammulinksnews.com
Stereotaxis (NYSEAMERICAN:STXS) Stock Price Down 2.5% – What’s Next? - Defense World
Stereotaxis Inc Stock (STXS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
22.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):